The effect of regular and enteric-coated aspirin on bleeding time, thromboxane, and prostacyclin
- 31 July 1993
- journal article
- clinical trial
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 49 (1), 515-520
- https://doi.org/10.1016/0952-3278(93)90040-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Aspirin in the Prevention of ThrombosisMedicine, 1991
- Selective inhibition of platelet cyclooxygenase with controlled release, low‐dose aspirinAustralian and New Zealand Journal of Medicine, 1990
- Metabolism of Aspirin after Therapeutic and Toxic DosesHuman & Experimental Toxicology, 1990
- Acetylsalicylic acid and the balance between prostacyclin and thromboxane A2Scandinavian Journal of Clinical and Laboratory Investigation, 1990
- Measurements of 6-keto-prostaglandin F1α and thromboxane B2 in bleeding time blood: relation to bleeding and vascular disorders?Canadian Journal of Physiology and Pharmacology, 1989
- EFFECT OF 50 mg ENTERIC‐COATED ASPIRIN (ASTRIX) ON THROMBOXANE AND PROSTACYCLIN SYNTHESISAnz Journal of Surgery, 1987
- A DOSE‐RANGING STUDY OF THE ANTIPLATELET EFFECT OF ENTERIC COATED ASPIRIN IN MANAustralian and New Zealand Journal of Medicine, 1987
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979